137 related articles for article (PubMed ID: 9546345)
1. Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product.
Gulley ML; Nicholls JM; Schneider BG; Amin MB; Ro JY; Geradts J
Am J Pathol; 1998 Apr; 152(4):865-9. PubMed ID: 9546345
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
3. Absence of nuclear p16 from Epstein-Barr virus-associated undifferentiated nasopharyngeal carcinomas.
Shibosawa E; Tsutsumi K; Koizuka I; Hoshikawa M; Takakuwa T
Laryngoscope; 2000 Jan; 110(1):93-7. PubMed ID: 10646722
[TBL] [Abstract][Full Text] [Related]
4. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
5. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
Lu DW; El-Mofty SK; Wang HL
Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
[TBL] [Abstract][Full Text] [Related]
6. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
7. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.
Subhawong AP; Subhawong T; Nassar H; Kouprina N; Begum S; Vang R; Westra WH; Argani P
Am J Surg Pathol; 2009 Feb; 33(2):163-75. PubMed ID: 18936692
[TBL] [Abstract][Full Text] [Related]
8. p53, p16 and RB expression in adenosquamous and squamous cell carcinomas of the stomach.
Lee WA; Woo DK; Kim YI; Kim WH
Pathol Res Pract; 1999; 195(11):747-52. PubMed ID: 10605694
[TBL] [Abstract][Full Text] [Related]
9. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
Muirhead DM; Hoffman HT; Robinson RA
J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
[TBL] [Abstract][Full Text] [Related]
10. [The expression of Rb, p16 and cyclin D1 in 41 esophageal cancers].
Zheng J; Zhou C; Xiao F
Zhonghua Bing Li Xue Za Zhi; 1996 Dec; 25(6):336-9. PubMed ID: 9388858
[TBL] [Abstract][Full Text] [Related]
11. The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma.
Stankiewicz E; Prowse DM; Ktori E; Cuzick J; Ambroisine L; Zhang X; Kudahetti S; Watkin N; Corbishley C; Berney DM
Histopathology; 2011 Feb; 58(3):433-9. PubMed ID: 21323963
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma.
Baba Y; Tsukuda M; Mochimatsu I; Furukawa S; Kagata H; Satake K; Koshika S; Nakatani Y; Hara M; Kato Y; Nagashima Y
Cancer Detect Prev; 2001; 25(5):414-9. PubMed ID: 11718447
[TBL] [Abstract][Full Text] [Related]
16. [Alterations of cell cycle regulating proteins: Rb, p21 and p16 in laryngeal cancer].
Pietruszewska W; Durko M; Kobos J
Otolaryngol Pol; 2007; 61(6):951-7. PubMed ID: 18546941
[TBL] [Abstract][Full Text] [Related]
17. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
18. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy.
Hwang CF; Cho CL; Huang CC; Wang JS; Shih YL; Su CY; Chang HW
Ann Oncol; 2002 Aug; 13(8):1246-51. PubMed ID: 12181248
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of cell cycle regulatory proteins in oropharyngeal carcinomas using tissue microarrays.
Ribeiro DA; Nascimento FD; Fracalossi AC; Gomes TS; Oshima CT; Franco MF
In Vivo; 2010; 24(3):315-20. PubMed ID: 20555005
[TBL] [Abstract][Full Text] [Related]
20. [Expression of six gene proteins in laryngeal carcinomas and their significance].
Wu X; He S; Wu M; Zhou L
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):648-51. PubMed ID: 16248464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
